Renaissance Technologies’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,892
| Closed | -$37.7K | – | 3867 |
|
|
2025
Q1 | $37.7K | Buy |
+34,892
| New | +$37.7K | ﹤0.01% | 3317 |
|
|
2024
Q4 | – | Sell |
-92,937
| Closed | -$116K | – | 3884 |
|
|
2024
Q3 | $116K | Buy |
92,937
+60,491
| +186% | +$75.6K | ﹤0.01% | 3234 |
|
|
2024
Q2 | $38.6K | Buy |
+32,446
| New | +$38.6K | ﹤0.01% | 3318 |
|
|
2024
Q1 | – | Sell |
-50,400
| Closed | -$53K | – | 4040 |
|
|
2023
Q4 | $53K | Buy |
+50,400
| New | +$53K | ﹤0.01% | 3444 |
|
|
2022
Q4 | – | Sell |
-22,400
| Closed | -$45K | – | 4386 |
|
|
2022
Q3 | $45K | Sell |
22,400
-11,438
| -34% | -$23K | ﹤0.01% | 3783 |
|
|
2022
Q2 | $75K | Buy |
+33,838
| New | +$75K | ﹤0.01% | 3912 |
|
|
2020
Q3 | – | Sell |
-14,360
| Closed | -$42K | – | 3657 |
|
|
2020
Q2 | $42K | Buy |
+14,360
| New | +$42K | ﹤0.01% | 3351 |
|
|
2019
Q4 | – | Sell |
-2,786
| Closed | -$17K | – | 3723 |
|
|
2019
Q3 | $17K | Sell |
2,786
-57,877
| -95% | -$353K | ﹤0.01% | 3380 |
|
|
2019
Q2 | $341K | Buy |
60,663
+34,223
| +129% | +$192K | ﹤0.01% | 3134 |
|
|
2019
Q1 | $1.35M | Buy |
26,440
+1,988
| +8% | +$101K | ﹤0.01% | 2528 |
|
|
2018
Q4 | $1.5M | Buy |
24,452
+8,895
| +57% | +$547K | ﹤0.01% | 2382 |
|
|
2018
Q3 | $949K | Buy |
15,557
+8,410
| +118% | +$513K | ﹤0.01% | 2626 |
|
|
2018
Q2 | $1.22M | Buy |
7,147
+3,966
| +125% | +$678K | ﹤0.01% | 2518 |
|
|
2018
Q1 | $549K | Buy |
3,181
+1,074
| +51% | +$185K | ﹤0.01% | 2881 |
|
|
2017
Q4 | $828K | Buy |
2,107
+260
| +14% | +$102K | ﹤0.01% | 2736 |
|
|
2017
Q3 | $977K | Buy |
1,847
+366
| +25% | +$194K | ﹤0.01% | 2583 |
|
|
2017
Q2 | $1.29M | Buy |
1,481
+414
| +39% | +$361K | ﹤0.01% | 2477 |
|
|
2017
Q1 | $976K | Buy |
+1,067
| New | +$976K | ﹤0.01% | 2550 |
|